ELI LILLY & Co
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3025% above fair value
$1410.99−6.55 (-0.46%)
Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%
Eli Lilly Cialis (tadalafil) by Quarter
Cialis (tadalafil) — Worldwide revenue YoY (%) [legacy] (%)
Eli Lilly Cialis (tadalafil): 5.0% in Q3 2024, up 30.0 pts from a year earlier. No newer figure appears in the documents we track.
Latest, Q3 2024
5.0%
Period ended Sep 30, 2024
Change on a year earlier
+30.0 pts
-25.0% in Q3 2023
History
20 quarters
Since Q1 2018
Sources
20
Documents cited below
Where the Q3 2024 figure comes from
“|| Cialis ® | 4.2 | 87.3 | 91.5 | 86.8 | 5”
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Eli Lilly Cialis (tadalafil) (%), quarterly Q1 2018–Q3 2024 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/med-cialis-yoy
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.